Kay Dickersin, PhD
Director, Center for Clinical Trials
Center & Institute Affiliation(s):
Baltimore , Maryland
Center for Clinical Trials and Evidence Synthesis: http://www.jhsph.edu/research/centers-and-institutes/johns-hopkins-center-for-clinical-trials/
PhD , Johns Hopkins University , 1989
Dr. Dickersin's major research interests are related to epidemiology, randomized clinical trials, systematic reviews and meta analysis, reporting biases, trials registers, peer review, evidence-based health care, and patient-centered outcomes research. She has conducted studies in a number of important subject areas, including women's health, eyes and vision, and surgery.
Dr. Dickersin serves as the Director for the Center for Clinical Trials and Evidence Synthesis http://www.jhsph.edu/research/centers-and-institutes/johns-hopkins-center-for-clinical-trials/, whose faculty, staff and students are involved in methodologic research related to clinical trials and evidence synthesis. She and the Clinical Trials & Evidence Synthesis faculty develop and implement the curriculum in the area of concentration by the same name.
She is also Director of the US Cochrane Center (USCC), one of 13 Centers worldwide participating in The Cochrane Collaboration (www.us.cochrane.org). The Collaboration aims to help people make well-informed decisions about health by preparing, maintaining, and promoting the accessibility of systematic reviews of available evidence on the benefits and risks of health care. The USCC hosts Consumers United for Evidence-based Healthcare (CUE) http://us.cochrane.org/consumers-united-evidence-based-healthcare-cue. Dr. Dickersin also serves as Director of the Cochrane Eyes and Vision Review Group, US Satellite. (CEVG@US)(www.eyes.cochrane.org).
Honors and Awards
1993 - 1997 Frohlich Fellowship, New York Academy of Sciences.
1994 “Woman of Excellence,” National Association of Women Business Owners, Baltimore Regional Chapter.
1995 Ellen Barnett Memorial Award, Susan B. Komen Foundation Race for the Cure.
1996 Women’s Hall of Fame, Baltimore City Commission for Women.
1998; 2006 “Maryland’s Top 100 Women,” Daily Record.
1998 MAMM magazine’s “50 Who Made a Difference.”
1999 Elected to membership, American Epidemiological Society.
2000 “Exceptional Advocate,” National Breast Cancer Coalition.
2007 "Contributions and Enduring Commitment to the Eradication of Cancer," American Association for Cancer Research.
2007 Elected to membership, Institute of Medicine
2009, 2013 JHSPH Student Assembly, Advising, Mentoring, Teaching Recognition Award (AMTRA)
2011 Elected Fellow, Society for Clinical Trials
2013 Valkhof Chair, Radboud Univerity Nijmegen Medical Centre in the Netherlands
2014 Ingram Olkin Award, from the Society for Research Synthesis Methods for lifetime contributions to the field
epidemiology, clinical trials, systematic reviews and meta-analysis, evidence-based health care, comparative effectiveness research, publication bias, trials registration, peer review, eyes and vision, women's health, the Cochrane Collaboration
Li T, Hutfless S, Scharfstein DO, Daniels MJ, Hogan JW, Little RJ, Roy JA, Law AH, Dickersin K. Standards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus. J Clin Epidemiol. 2014; 7(1):15-32. doi: 10.1016/j.jclinepi.2013.08.013. PMID: 24262770.
Dickersin K. To reform U.S. health care, start with systematic reviews. Science 329(5991):516-7, 2010.
Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med 361:1963-71, 2009.
Moher D, Liberati A, Tetzlaff, J, Altman D, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med 6:7 July, 2009.